The Multiple Sclerosis Disease Activity test, which measures proteins to assess disease activity, has been available in the U ...

Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a ...

A new partnership will bring three new medications to the Middle East and North Africa, including an Ocrevus biosimilar drug ...

Most children with MS have chronic lesions that slowly get bigger over time, but their frequency doesn't correlate with ...

Anne, who has MS, shares why it's important to speak up, seek second opinions, or switch doctors to take charge of your care and feel heard.

The FDA gave Hope Bioscience's stem cell therapy RMAT designation after clinical data suggested it may improve life for ...

Columnist Ben Hofmeister, who didn't really have a wish list of must-do activities before his MS diagnosis, shares his "MS bucket list." ...

Most MS neurologists in the US have received physician pharma payments, and a study suggests this may influence their ...

To explain his MS to his sons, Ben Hofmeister fell back on his old Army training when someone was learning something new — crawl, walk, run.

After 14 reported cases, Health Canada is warning that glatiramer acetate products for MS can cause anaphylaxis, a severe allergic reaction.

A study identified a protein that stalls myelin repair in the brain, suggesting that targeting it could be a strategy for MS treatment.